La plateforme de cytométrie du CRCHUM a contribué à la publication des articles scientifiques suivants : 


1. Abdelnabi, M. N., M. Flores Molina, G. Soucy, V. Quoc-Huy Trinh, N. Bedard, S. Mazouz, ... N. H. Shoukry. Sex-Dependent Hepatoprotective Role of IL-22 Receptor Signaling in Non-Alcoholic Fatty Liver Disease-Related Fibrosis. Cell Mol Gastroenterol Hepatol. 2022;14(6):1269-1294.

2. Aranguren, M., K. Doyon-Laliberte, M. El-Far, C. Chartrand-Lefebvre, J. P. Routy, J. G. Barril, ... S. Aging Cohort. Subclinical Atherosclerosis Is Associated with Discrepancies in BAFF and APRIL Levels and Altered Breg Potential of Precursor-like Marginal Zone B-Cells in Long-Term HIV Treated Individuals. Vaccines (Basel). 2022;11(1).

3. Beaudoin-Bussieres, G., A. Arduini, C. Bourassa, H. Medjahed, G. Gendron-Lepage, J. Richard, ... A. Finzi. SARS-CoV-2 Accessory Protein ORF8 Decreases Antibody-Dependent Cellular Cytotoxicity. Viruses. 2022;14(6).

4. Boutin, M., D. Vezina, S. Ding, J. Prevost, A. Laumaea, L. Marchitto, ... A. Finzi. Temsavir Treatment of HIV-1-Infected Cells Decreases Envelope Glycoprotein Recognition by Broadly Neutralizing Antibodies. mBio. 2022;13(3):e0057722.

5. Castell, A. L., C. Goubault, M. Ethier, G. Fergusson, C. Tremblay, M. Baltz, ... V. Poitout. beta Cell mass expansion during puberty involves serotonin signaling and determines glucose homeostasis in adulthood. JCI Insight. 2022;7(21).

6. Castell, A. L., A. Vivoli, T. S. Tippetts, I. R. Frayne, Z. E. Angeles, V. S. Moulle, ... V. Poitout. Very-Long-Chain Unsaturated Sphingolipids Mediate Oleate-Induced Rat beta-Cell Proliferation. Diabetes. 2022;71(6):1218-1232.

7. Ding, S., I. Ullah, S. Y. Gong, J. R. Grover, M. Mohammadi, Y. Chen, ... C. Baron. VE607 stabilizes SARS-CoV-2 Spike in the "RBD-up" conformation and inhibits viral entry. iScience. 2022;25(7):104528.

8. Fournier, A. P., S. Zandee, M. Charabati, E. Peelen, O Tastet, J. I. Alvarez, ... A. Prat. CLMP Promotes Leukocyte Migration Across Brain Barriers in Multiple Sclerosis. Neurol Neuroimmunol Neuroinflamm. 2022;9(6). The authors are grateful to the CRCHUM animal facility led by H. Héon, imaging

9. Gong, S. Y., S. Ding, M. Benlarbi, Y. Chen, D. Vezina, L. Marchitto, ... A. Finzi. Temperature Influences the Interaction between SARS-CoV-2 Spike from Omicron Subvariants and Human ACE2. Viruses. 2022;14(10)

10. Laumaea, A. E., A. Lewin, D. Chatterjee, L. Marchitto, S. Ding, G. Gendron-Lepage, ... R. Bazin. COVID-19 vaccine humoral response in frequent platelet donors with plateletpheresis-associated lymphopenia. Transfusion. 2022;62(9):1779-1790.

11. Lemaitre, F., N. Farzam-Kia, A. Carmena Moratalla, Y. Carpentier Solorio, M. L. Clenet, O. Tastet, . . . N. Arbour. IL-27 shapes the immune properties of human astrocytes and their impact on encountered human T lymphocytes. J Neuroinflammation. 2022;19(1):212.

12. Mazouz, S., E. Salinas, N. Bedard, A. Filali, O. Khedr, L. Swadling, ... N. H. Shoukry. Differential immune transcriptomic profiles between vaccinated and resolved HCV reinfected subjects. PLoS Pathog. 2022;18(11):e1010968.

13. Nayrac, M., M. Dube, G. Sannier, A. Nicolas, L. Marchitto, O. Tastet, ... D. E. Kaufmann. Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen. Cell Rep. 2022;39(13):111013.

14. Prevost, J., S. P. Anand, J. K. Rajashekar, L. Zhu, J. Richard, G. Goyette, ... A. Finzi. HIV-1 Vpu restricts Fc-mediated effector functions in vivo. Cell Rep. 2022;41(6):111624.

15. Tauzin, A., G. Beaudoin-Bussieres, S. Y. Gong, D. Chatterjee, G. Gendron-Lepage, C. Bourassa, ... A. Finzi. Humoral immune responses against SARS-CoV-2 Spike variants after mRNA vaccination in solid organ transplant recipients. iScience. 2022;25(9):104990.

16. Tauzin, A., S. Y. Gong, D. Chatterjee, S. Ding, M. M. Painter, R. R. Goel, ... A. Finzi. A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two doses. Cell Rep. 2022;41(4):111554.


Cette information est-elle utile?
Laissez-nous savoir comment nous pouvons améliorer le site pour mieux répondre à vos besoins.